Agilent Technologies Analysis of beta-blocking drugs on Agilent 1100 Series LC systems using UV, fluorescence and mass spectrometry detection

安捷伦 的其他说明书

• Agilent Technologies Determination of Opiates and Metabolites in Blood Using Electrospray LC/MS
• Agilent Technologies Using Software Tools to Improve the Detection of Impurities by LC/MS
• Agilent Technologies Determination of Digoxin in Human Serum by LC/MS with Online Sample Preparation
• Agilent Technologies Rapid Analysis of Drugs of Abuse by LC/Triple Quadrupole Mass Spectrometry
• Agilent Technologies Analysis of a complex natural product extract from ginseng - Part II: Structure elucidation of ginsenosides by high resolution ion trap LC/MS
• Agilent Technologies Identification of red and white blood cells from whole blood samples using the Agilent 2100 bioanalyzer
• Agilent Technologies Separation of Explosives in EPA 8330: Column Choices Optimize Speed, Resolution, and Solvent Use
• Agilent Technologies A Column-Flow Independent Configuration for QuickSwap
• Agilent Technologies Developing a fast, generic method for rapid resolution LC with quadrupole MS detection
• Agilent Technologies Fast LC analysis with quadrupole MS detection – without loss of spectral quality
• Agilent Technologies 21 CFR Part 11 Compliance Features of the LC/MSD Trap Security Pack 1.0 Software
• Agilent Technologies Analysis of metabolites from beta blocking drugs in biological samples using an Agilent 1100 Series capillary LC/Trap XCT system
• Agilent Technologies Comparison of Sensitivity and Spectra between the AP-MALDI LC/MSD Trap SL System and Traditional Vacuum MALDI-TOF
• Agilent Technologies Using the Expanded Capabilities of the LC/MSD Trap Software Version 4.2
• Agilent Technologies Positive and Negative Mode Analyses with the Agilent 1100 Series LC/MSD Trap

查看 安捷伦 全部说明书 →